注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Imunon Inc(原名:Celsion Corporation),是一家臨床階段的生物技術公司。該公司專注於通過臨床試驗推進一系列治療方法,包括基於脫氧核糖核酸(DNA)的免疫療法、疫苗和定向化學療法。其主要臨床項目GEN-1,一種基於DNA的免疫療法,用於晚期卵巢癌的局部治療。GEN-1的作用是指導身體在腫瘤部位產生抗癌分子,例如白細胞介素12和乾擾素γ。公司擁有兩項平台技術:TheraPlas平台用於開發基於核酸的免疫療法和疫苗,以及其他抗癌DNA或核糖核酸(RNA)療法,其PLACCINE平台用於開髮用於感染性疾病的核酸疫苗和癌症。其平台技術基於獨立於病毒載體或裝置的新型合成遞送系統的核酸遞送。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Michael H. Tardugno | 71 | 2007 | Executive Chairman |
Donald P. Braun | 74 | 2015 | Independent Director |
Wafik El-Deiry | - | - | Member of Advisory Board |
Frederick J. Fritz | 73 | 2011 | Independent Director |
Mark W. Dewhirst | - | - | Member of Advisory Board |
Michael E. Weinblatt | - | - | Member of Advisory Board |
David Cheresh | - | - | Member of Advisory Board |
Jerry Glickson | - | - | Member of Advisory Board |
Britt A. Glaunsinger | - | 2021 | Member of the Advisory Board |
Luke D. Handke | - | 2021 | Member of Vaccine Advisory Board |
Patrick Ott | - | 2023 | Member of Scientific Advisory Board |
Peter Corry | - | - | Member of Advisory Board |
Stacy R. Lindborg | 54 | 2021 | Independent Director |
Xinzhen Yang | - | 2021 | Member of the Advisory Board |
Christine A. Pellizzari | 56 | 2021 | Independent Director |
Dan H. Barouch | - | 2021 | Member of Vaccine Advisory Board |
Sachet A. Shukla | - | 2023 | Member of Scientific Advisory Board |
James E. Dentzer | 57 | 2022 | Independent Director |
John W. Shiver | - | - | Member of Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核